Patent · US Active

Pyrrolo[2,3-D]pyrimidine derivatives

US9035074B2 · kind B2 · utility

5Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 2014
Grant dateMay 19, 2015
Priority date—
Expiry dateFeb 19, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D207/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.